Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Infliximab-induced nonspecific interstitial pneumonia.

Sen S, Peltz C, Jordan K, Boes TJ.

Am J Med Sci. 2012 Jul;344(1):75-8. doi: 10.1097/MAJ.0b013e31824c07e8.

PMID:
22688498
2.

Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections.

Schneeweiss S, Korzenik J, Solomon DH, Canning C, Lee J, Bressler B.

Aliment Pharmacol Ther. 2009 Aug;30(3):253-64. doi: 10.1111/j.1365-2036.2009.04037.x. Epub 2009 May 6.

3.

Infliximab-induced reactivated Langerhan's cell histiocytosis in a patient with ulcerative colitis.

Rodríguez HN, García I, Alba A, Igea F.

Inflamm Bowel Dis. 2009 Sep;15(9):1286-7. doi: 10.1002/ibd.20796. No abstract available.

PMID:
18942740
4.

Case records of the Massachusetts General Hospital. Case 33-2008. A 63-year-old woman with dyspnea on exertion.

Wiener CM, Muse VV, Mark EJ.

N Engl J Med. 2008 Oct 23;359(17):1823-32. doi: 10.1056/NEJMcpc0806979. No abstract available.

PMID:
18946068
5.

A case of interstitial pneumonitis in a patient with ulcerative colitis treated with azathioprine.

Nagy F, Molnar T, Makula E, Kiss I, Milassin P, Zollei E, Tiszlavicz L, Lonovics J.

World J Gastroenterol. 2007 Jan 14;13(2):316-9.

6.

Interstitial lung disease induced or exacerbated by TNF-targeted therapies: analysis of 122 cases.

Perez-Alvarez R, Perez-de-Lis M, Diaz-Lagares C, Pego-Reigosa JM, Retamozo S, Bove A, Brito-Zeron P, Bosch X, Ramos-Casals M.

Semin Arthritis Rheum. 2011 Oct;41(2):256-64. doi: 10.1016/j.semarthrit.2010.11.002. Epub 2011 Feb 1.

PMID:
21277618
7.

Noninfectious interstitial lung disease during infliximab therapy: case report and literature review.

Caccaro R, Savarino E, D'Incà R, Sturniolo GC.

World J Gastroenterol. 2013 Aug 28;19(32):5377-80. doi: 10.3748/wjg.v19.i32.5377. Review.

8.

[Infliximab in moderate to severe steroid-dependent or steroid-refractory ulcerative colitis].

Mocciaro F, Orlando A, Scimeca D, Cottone M.

Recenti Prog Med. 2007 Nov;98(11):560-4. Italian.

PMID:
18044405
9.

Infliximab efficacy in pediatric ulcerative colitis.

Eidelwein AP, Cuffari C, Abadom V, Oliva-Hemker M.

Inflamm Bowel Dis. 2005 Mar;11(3):213-8.

PMID:
15735427
10.

Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus.

Yamamoto S, Nakase H, Matsuura M, Honzawa Y, Masuda S, Inui K, Chiba T.

J Gastroenterol Hepatol. 2010 May;25(5):886-91. doi: 10.1111/j.1440-1746.2009.06206.x.

PMID:
20546441
11.

Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients.

Aringer M, Houssiau F, Gordon C, Graninger WB, Voll RE, Rath E, Steiner G, Smolen JS.

Rheumatology (Oxford). 2009 Nov;48(11):1451-4. doi: 10.1093/rheumatology/kep270. Epub 2009 Sep 11.

PMID:
19748965
12.

Interstitial pneumonitis associated with infliximab therapy.

Villeneuve E, St-Pierre A, Haraoui B.

J Rheumatol. 2006 Jun;33(6):1189-93. Epub 2006 Apr 15.

PMID:
16622902
13.

Infliximab or cyclosporine for acute severe ulcerative colitis: a retrospective analysis.

Dean KE, Hikaka J, Huakau JT, Walmsley RS.

J Gastroenterol Hepatol. 2012 Mar;27(3):487-92. doi: 10.1111/j.1440-1746.2011.06958.x.

PMID:
22098019
14.

[Pneumocystis jiroveci pneumonia during infliximab therapy].

Josephson ME, Kristensen LH, Andersen VC.

Ugeskr Laeger. 2008 Jun 9;170(24):2159-60. Danish.

PMID:
18565304
15.

[Interstitial pneumonia after infliximab therapy for psoriasis].

Leger S, Etienne M, Duval-Modeste AB, Roussel A, Caron F, Thiberville L.

Ann Dermatol Venereol. 2011 Jun-Jul;138(6-7):499-503. doi: 10.1016/j.annder.2011.01.043. Epub 2011 Mar 21. French.

PMID:
21700071
16.

Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitis.

Lawson MM, Thomas AG, Akobeng AK.

Cochrane Database Syst Rev. 2006 Jul 19;(3):CD005112. Review.

PMID:
16856078
17.

[Azathioprine-associated interstitial pneumonitis].

Nagy F, Molnár T, Makula E, Kiss I, Milassin P, Zöllei E, Tiszlavicz L, Lonovics J.

Orv Hetil. 2006 Feb 12;147(6):259-62. Hungarian.

PMID:
16610616
18.

Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study.

Sands BE, Tremaine WJ, Sandborn WJ, Rutgeerts PJ, Hanauer SB, Mayer L, Targan SR, Podolsky DK.

Inflamm Bowel Dis. 2001 May;7(2):83-8.

PMID:
11383595
19.

Review article: why, when and how to de-escalate therapy in inflammatory bowel diseases.

Pariente B, Laharie D.

Aliment Pharmacol Ther. 2014 Aug;40(4):338-53. doi: 10.1111/apt.12838. Epub 2014 Jun 23. Review.

20.

Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases.

Ramos-Casals M, Brito-Zerón P, Muñoz S, Soria N, Galiana D, Bertolaccini L, Cuadrado MJ, Khamashta MA.

Medicine (Baltimore). 2007 Jul;86(4):242-51.

Supplemental Content

Support Center